Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Choline Deficiency · Liver Injury

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Colorado School of Medicine, Aurora, Colorado, United States

    Contact: Study coordinator (Use Central Contact)
  • Floridian Clinical Research, Miami Lakes, Florida, United States

    Contact: Study coordinator (Use Central Contact)
  • Nebraska Medicine, Omaha, Nebraska, United States

    Contact: Study coordinator (Use Central Contact)
  • Columbia University Medical Center/ New York Presbyterian Hospital, New York, New York, United States

    Contact: Study coordinator (Use Central Contact)
  • Duke Clinic - Abdominal Transplant Research Office, Durham, North Carolina, United States

    Contact: Study coordinator (Use Central Contact)
  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Use Central Contact)
  • Pinnacle Clinical Research- San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (Use Central Contact)
  • University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium

    Contact: Study coordinator (Use Central Contact)
  • Aalborg University Hospital, Department of Medical Gastroenterology, Aalborg, Denmark

    Contact: Study coordinator (Use Central Contact)
  • Rigshospitalet - University Hospital Copenhagen, Copenhagen, Denmark

    Contact: Study coordinator (Use Central Contact)
  • Beaujon Hospital - APHP, Clichy, France

    Contact: Study coordinator (Use Central Contact)
  • Rennes University Hospital Center - Pontchaillou Site, Rennes, France

    Contact: Study coordinator (Use Central Contact)
  • CHRU Nancy - Barbois Hospital, Vandœuvre-lès-Nancy, France

    Contact: Study coordinator (Use Central Contact)
  • Charite - University Hospital Berlin, Berlin, Germany

    Contact: Study coordinator (Use Central Contact)
  • University Duisburg-Essen, University Hospital Essen, Essen, Germany

    Contact: Study coordinator (Use Central Contact)
  • M. Pirogow Provincial Specialized Hospital in Lodz, Nutritional Treatment Center, Lodz, Poland

    Contact: Study coordinator (Use Central Contact)
  • Czerniakowski Hospital Sp. z o.o. (LCC), Warsaw, Poland

    Contact: Study coordinator (Use Central Contact)
Study leads
  • Chief Scientific Operations Officer

    Study Director

    Protara Therapeutics